Arcutis Biotherapeutics (ARQT) Event Aug. 04, 2022, 00:00 UTC (75% Positive) ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Reports 41% Loss Reduction for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 12:33 p.m. 🏢 Arcutis Biotherapeutics (ARQT) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-04 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-78.05M $-131.73M $53.68M +40.75% 📉 Total Assets $408.15M $300.46M $107.69M +35.84% 📈 Total Liabilities $110.47M $105.08M $5.39M +5.13% 📉 Stockholders' Equity $195.38M $-540.04M $735.42M +136.18% 📈 Operating Income/Loss $-78.17M $-128.46M $50.29M +39.15% 📉 R&D Expense $52.40M $78.83M $-26.43M -33.53% 📈 Earningspersharebasic $-1.60 $-2.58 $0.98 +37.98% 📈 Earningspersharediluted $-1.60 $-2.58 $0.98 +37.98% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Arcutis Biotherapeutics (ARQT) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document